PubMed:32178765 / 0-193
Annnotations
yaoziqian_800_3
{"project":"yaoziqian_800_3","denotations":[{"id":"T1","span":{"begin":0,"end":10},"obj":"CI"},{"id":"T2","span":{"begin":35,"end":54},"obj":"DP"},{"id":"T25","span":{"begin":173,"end":180},"obj":"CI"}],"text":"Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled p"}
Zierdiyeerkenaili_800_3
{"project":"Zierdiyeerkenaili_800_3","denotations":[{"id":"T1","span":{"begin":0,"end":10},"obj":"CI"},{"id":"T5","span":{"begin":35,"end":54},"obj":"DP"},{"id":"T19","span":{"begin":173,"end":180},"obj":"CI"}],"text":"Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled p"}